RAPP is Rapport Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $48.69. Market cap: $2.34B. Capital Quality Rank: 50/100 — Stagnant mediocrity.
Stock snapshot
| Price | $48.69 |
| Market cap | $2.34B |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 50 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -5.5% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Safe |
About RAPP
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
Related non-dividend companies
Other non-dividend stocks investors research alongside RAPP. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is RAPP's current stock price?
RAPP (Rapport Therapeutics, Inc.) is currently trading at $48.69.
Does RAPP pay a dividend?
RAPP (Rapport Therapeutics, Inc.) does not currently pay a regular dividend.
What is RAPP's Capital Quality Rank?
RAPP has a Capital Quality Rank of 50/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track RAPP in DiviDrip
Add RAPP to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search RAPP and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.